UPSIDA offers plots for pharma manufacturing units in Lalitpur

Lucknow:  To encourage investment in the pharmaceutical industry, the Uttar Pradesh State Industrial Development Authority (UPSIDA) launched a project for the allocation of industrial plots under the ‘Bulk Drug and Formulation Pharma Park’ in Lalitpur.

According to officials, the scheme will commence on April 21. The allocation rate for industrial plots will be Rs 1,914 per square meter. Any unit that makes a one-time payment after allotment will receive an additional 2% rebate.

The project is equipped with several key facilities to ensure a robust and secure infrastructure, including roads, a common logistics and commercial area, and dedicated space for commercial activities and logistics operations. The premises will be secured with proper fencing. A system has been developed to reduce waterlogging issues, and a centre will provide rapid assistance during emergencies. Waste management infrastructure with a capacity of 3.53 TPD (Tons Per Day) has been implemented, along with a steam distribution network with a capacity of 75 TPH (Tons Per Hour) for industrial processes.

A 33/11 kV substation distribution network will supply power within the project area. Lalitpur is well-connected via road, rail, and air routes, making it highly strategic for development and accessibility. MDR 35B (Major District Road) passes through Lalitpur, playing a key role in local and regional transport. NH 44 (approximately 44 km away) and NH 539 (around 31 km away) also serve the area. The region is served by Tikamgarh Railway Station (35 km) and Lalitpur Railway Junction (50 km), linking it with various parts of the country. Khajuraho Airport (125 km) and Lucknow Airport (385 km) are major options for air travel.

Additionally, a local airstrip located 50 km from Lalitpur further enhances the region’s development prospects. Interested parties can obtain or download the list of available plots, terms and conditions, guidelines, and application forms from the following websites: [www.niveshmitra.up.nic.in](http://www.niveshmitra.up.nic.in) and [www.onlineupsida.com](http://www.onlineupsida.com).

Chief Executive Officer of UPSIDA, Mayur Maheshwari, stated, “The upcoming Bulk Drug and Formulations Pharma Park in Lalitpur will be a game-changer in the state’s industrial sector. It will enhance self-reliance in the pharma industry and provide modern facilities for businesses.”

Related Posts

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

In a significant step towards leveraging emerging technologies to strengthen the Ayush ecosystem, the Ministry of Ayush and IndiaAI, ministry of electronics and information technology (MeitY), signed a Memorandum of…

BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

Punjab Police recently dismantled an interstate cheating operation linked to the BFUHS pharmacy exam. Education Minister Harjot Bains described it as a sophisticated, technology-driven scheme rather than a paper leak.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

Rajasthan Raises Govt Blood Centres’ Share in Voluntary Donation Camps to 50%

Rajasthan Raises Govt Blood Centres’ Share in Voluntary Donation Camps to 50%

FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims